Table 5.
Variable | Outcome | Frequency (n) | Percentage (%) |
---|---|---|---|
Preferred Vaccine Type | mRNA-based Vaccine | 212 | 58.6% |
Viral Vector-based Vaccine | 24 | 6.6% | |
Inactivated Virus Vaccine | 12 | 3.3% | |
None | 114 | 31.5% | |
First Priority | Safe for the child | 209 | 61.5% |
Safe for the mother | 63 | 18.5% | |
Effective for the child | 44 | 12.9% | |
Effective for the mother | 24 | 7.1% | |
Second Priority | Safe for the child | 61 | 18.5% |
Safe for the mother | 155 | 47% | |
Effective for the child | 61 | 18.5% | |
Effective for the mother | 53 | 16.1% | |
Third Priority | Safe for the child | 36 | 10.9% |
Safe for the mother | 68 | 20.6% | |
Effective for the child | 116 | 35.2% | |
Effective for the mother | 110 | 33.3% | |
Fourth Priority | Safe for the child | 27 | 8.2% |
Safe for the mother | 50 | 15.1% | |
Effective for the child | 137 | 41.4% | |
Effective for the mother | 117 | 35.3% |
Missing data ranged between 6.1% to 8.8%.